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From 1988 to 2003 Stephen Hilgartner conducted extensive ethnographic fieldwork in and around what 
came to be known as the Human Genome Project. He conducted this work predominantly in the United 
States, but also in the United Kingdom, France, and Germany. This timing granted him, and now us, 
privileged access to the actors and places involved in the development of what we might call the ‘official’ 
Human Genome Project (HGP). This is of considerable value, but it also comes with the challenge of 
writing a book that necessarily involves historical narrative using an ethnographic approach.  
 
The central argument of the book relies on the articulation and deployment of the concepts of ‘knowledge-
control regimes’ and ‘governing frames’, by which the changes that occur over the course of the HGP are 
interpreted. The former is “a sociotechnical arrangement that constitutes categories of agents, spaces, 
objects, and relationships among them in a manner that allocates entitlements and burdens pertaining to 
knowledge” (p. 9). The latter is “an organized set of schemata that individuals and collectives use to 
interpret situations or activities as being instances of a particular kind of event or deed” (p. 11).  
 
Hilgartner builds the case that throughout the history of the HGP, new knowledge-control regimes 
successively replaced previous ones that were no longer viable, for instance due to groups having sequence 
data poached and used in publications by others before they were able to make use of the data themselves. 
The knowledge-control regimes that succeeded those too burdened with problems to survive were, 
Hilgartner details, ones which caused the least initial disruption to the governing frames that were already 
in place. 
 
This well-supported argument is partially obscured by bookending the work as a whole (and individual 
chapters) with an emphasis on ‘revolution’ and the visions of a vaguely defined ‘genomics vanguard’. 
Rather than use these terms, Hilgartner may have served his overall argument more effectively by threading 
the concept of ‘holdings’ in tandem with his own articulation of ‘perimeters’ (introduced in Chapter 3) 
throughout the succeeding chapters. Holdings are “the knowledge objects found in the laboratory” that are 
“evolving assemblages” of “unequal ‘strategic value’” (p. 65). Through “dynamic management of an 
emphatically breachable boundary”—the perimeter—the head of a laboratory has control and discretion 
over the selective transfer of holdings in and out of their laboratory (p. 67). These successfully characterise 
the control processes in individual laboratories that existed before the establishment of large-scale genome 
centres. However, barring a brief reappearance in the conclusion (p. 225), the concepts of holdings and 
perimeter and the discussion of the practices involved in their management are not used in the succeeding 
chapters, though there are many appropriate areas where invoking them would have been both salient and 
fruitful, for example in framing chapter 6 on the changes in knowledge-control regimes concerning the 
submission of sequence data to databases.   
 
Hilgartner asserts rhetorical and methodological commitment to the examination of the dynamic processes 
underlying both the stabilisation and destabilisation of regimes. This works well in chapter 4’s comparative 
discussion of the knowledge-control regimes exhibited by the US human genome program’s approach to 
data submission and that of the Reference Library System initiated by Hans Lehrach at the Imperial Cancer 
Research Fund in the UK. The former persisted as “changes in the US program introduced at the outset of 
the HGP were consistent with preserving, not altering, the individualistic culture and practices of molecular 
biology” (p. 122). However, one was a major nationally-funded effort with the aim of completion, the 
other, a smaller charitably-funded effort that did not aim at completion. This leads one to question the 
extent to which conclusions can be drawn from a comparison of them.  
 
Chapter 4’s engaging comparative study is told primarily through ethnographic data and extensive quotes 
from his anonymised interlocutors. In providing a historical account, however, people and their institutional 
affiliations matter. In the valuable appendix to the book where Hilgartner discusses the methodological 
challenges of his work, he acknowledges the problem with anonymity, but defends the use of anonymised 
quotes, as he is studying social structures rather than individual scientists and institutions. Nevertheless, the 
particularities are relevant to an understanding of social structures and processes, certainly in the more 
historically-oriented chapters.  
 
Chapters 5 and 6 are the strongest. They constitute exceptional examinations of the development and 
adoption of expressed sequence tags (ESTs) and the changing practices, expectations, and agreements 
concerning the submission and publication of sequence data. In these chapters, the ethnographic data is 
used to detail the conceptual points against the essential background of an artfully elaborated historical 
narrative in which people and institutions are named. In these chapters, the concept of knowledge-control 
regimes has its most powerful analytical purchase in well-articulated discussions of shifts of regime.  
 
In the earliest stages of various initiatives to sequence the human genome on a systematic basis, there were 
proponents of sequencing cDNA—DNA reverse transcribed from mRNA that thus represented the coding 
portion of the genome. Advocates of this approach emphasised that functional or coding DNA should be a 
priority for sequencing due to its likely relevance to research concerning the role of genes in particular 
diseases. Those who argued for a project aiming to sequence the full genome feared that a partial approach 
based on a problematic division of the genome into important and irrelevant parts would undermine support 
for whole-genome sequencing. The NIH-led programme in the United States opted for the whole genome 
approach (with some cDNA sequencing as a minor part), whereas other projects such as the UK’s Human 
Genome Mapping Project were based on the cDNA approach.  
 
At this time, Craig Venter was still at the NIH’s National Institute of Neurological Diseases and Stroke. 
Frustrated with the slow pace of the overall HGP, he pioneered an approach towards partial sequencing of 
cDNAs, producing ESTs. He and his group then used the partial sequence data to search the sequence 
database GenBank for corresponding sequences associated with genes that had already been found, for 
example in other species. Through this, partial cDNA sequencing was repackaged by Venter as tools for 
finding and indexing genes. As Hilgartner observes, “Venter transformed the job to match the tool” (p. 
130). Work centred on the sequencing of ESTs and indexing genes circumvented the problem faced by 
more systematic efforts. ESTs here have a role as intermediaries, valued for what they can help find rather 
than in themselves. For Venter it wasn’t all about finishing the genome but finding areas of the genome 
with potential use in biomedical research.   
 
The prospect of patenting ESTs led to a crisis within the NIH-funded initiative, mistrust from international 
partners, and a debate about the epistemic as well as potential commercial value of ESTs (p. 135). Fearing 
the consequences of allowing ESTs and data concerning them to be held privately by biotechnology 
companies, a coalition of HGP scientists and the pharmaceutical company Merck (who funded the 
initiative) came together and established an open, publicly-accessible EST database, the Merck Gene Index. 
Merck also funded a programme to generate huge numbers of ESTs for deposition into GenBank’s EST 
database. These moves transformed the EST into an “ordinary tool” and deflated their commercial value, 
forcing the companies that were built around them to explore alternative strategies (p. 150-151).  
 
Hilgartner’s argument is that “between the late 1980s and roughly 1996 […] a series of distinct knowledge 
objects took shape: namely, the cDNA strategy, the EST, the EST patent, the proprietary EST database, the 
public EST database, and finally the EST as an ordinary tool.” These changes constitute for Hilgartner 
“transformations of strategic objectives, material practices, organizational structures, and, not least, 
knowledge-control regimes.” (p. 152). The focus on cDNA and ESTs provides a welcome alternative 
approach to the predominant narratives of the HGP. Particularly intriguing is the discussion of the change 
in epistemic status and valuation of ESTs.  
 
After discussing earlier challenges of getting sequence data onto public databases, he describes the advent 
of a regime based on progressively brisker submission of sequence data and open public access to that data. 
The consequence was the progressive separation of producer and user, which culminated in sequencing 
increasingly taking place on a large-scale at a small number of centres—the so-called G5. While 
Hilgartner’s focus is on the advent of the knowledge-control regime associated with the publicly and 
charitably funded G5, alternative approaches to sequencing and the use of sequence data existed. These 
included smaller-scale sequencing activities that have not yet been fully captured by historical accounts of 
sequencing and genomics, and Venter’s private-sector effort. Hilgartner hints at the incompatibility of the 
knowledge-control regimes of the public HGP and the Venter-led programme. I would have liked to see 
this developed further and the potential consequences explored.  
 
Overall, Hilgartner’s discussions of the regimes associated with the cDNA and ESTs break significant new 
ground, and present a strikingly original and compelling perspective on the HGP and its development. The 
central argument concerning the succession of knowledge-control regimes and the implications of this 
provides a fertile basis for further research, including how the increasing abstraction of the domains of the 
production of sequence data and the use of sequence data took place, what its consequences were for 
translation, and how smaller-scale sequencing operations fit into and around the knowledge-control 
regimes and governing frames that emerged thereafter. 
 
More broadly, the book offers a well-written and engaging discussion of the HGP that will be interesting 
and enriching for general readers. The technical descriptions and illustrations are clear, concise, and 
precise. To those who work on genomics from historical, philosophical, social scientific, and 
anthropological approaches, it offers this as well as considerable resources, perspectives, and plenty of 
empirical detail to provoke new insights and lines of investigation. 
 
